MTOR and diabetes mellitus: Management of post-transplant diabetes can be challenging, as immunosuppressive drugs such as glucocorticoids, calcineurin inhibitors, and mTOR (mammalian target of rapamycin) inhibitors are associated with induction of hyperglycemia or worsening of glucose control.